drugset
drugset / Trial / NCT03886103

Pharmacokinetics and Metabolism of (14C)-Labelled PXL770

NCT03886103 ↗

Phase 1 Completed 8 enrolled Poxel SA
NaSingle-groupOpen-labelTreatment

Summary

This is a single-dose, single center, single-period, open-label, non-randomized, mass balance recovery study in healthy male subjects.

Timeline

Start
2019-02-06
Primary completion
2019-03-15
Completion
2019-03-15

Drugs

EvaluationDrugModalityDoseRoute
Subject PXL770 Unknown — Oral

Indications

No indication recorded.